Skip to main content
. 2022 Apr 14;8:200. doi: 10.1038/s41420-022-00996-5

Fig. 6. SNORD1C was upregulated in CRC, which activated the canonical Wnt/β-catenin pathway and promoted the development of cancer stem cells.

Fig. 6

Together, these increased β-catenin expression and that of the transcription factor TCF7, which led to increased expression of the target gene MYC. Furthermore, binding to the stem cell regulator SOX2 promoted cancer development and enhanced chemotherapy resistance.